218 related articles for article (PubMed ID: 15110849)
1. Differential effects of synthesized 2'-oxygenated chalcone derivatives: modulation of human cell cycle phase distribution.
Rao YK; Fang SH; Tzeng YM
Bioorg Med Chem; 2004 May; 12(10):2679-86. PubMed ID: 15110849
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of 3',4',5'-trimethoxychalcone analogues as inhibitors of nitric oxide production and tumor cell proliferation.
Rao YK; Fang SH; Tzeng YM
Bioorg Med Chem; 2009 Dec; 17(23):7909-14. PubMed ID: 19875299
[TBL] [Abstract][Full Text] [Related]
3. Studies of structure-activity relationship on plant polyphenol-induced suppression of human liver cancer cells.
Loa J; Chow P; Zhang K
Cancer Chemother Pharmacol; 2009 May; 63(6):1007-16. PubMed ID: 18766342
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of Mannich bases of heterocyclic chalcone analogs as cytotoxic agents.
Reddy MV; Su CR; Chiou WF; Liu YN; Chen RY; Bastow KF; Lee KH; Wu TS
Bioorg Med Chem; 2008 Aug; 16(15):7358-70. PubMed ID: 18602831
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, growth inhibition, and cell cycle evaluations of novel flavonoid derivatives.
Rao YK; Fang SH; Tzeng YM
Bioorg Med Chem; 2005 Dec; 13(24):6850-5. PubMed ID: 16140534
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacological effect.
Vogel S; Barbic M; Jürgenliemk G; Heilmann J
Eur J Med Chem; 2010 Jun; 45(6):2206-13. PubMed ID: 20153559
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E
Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic events induced by synthetic naphthylchalcones in human acute leukemia cell lines.
Maioral MF; Gaspar PC; Rosa Souza GR; Mascarello A; Chiaradia LD; Licínio MA; Moraes AC; Yunes RA; Nunes RJ; Santos-Silva MC
Biochimie; 2013 Apr; 95(4):866-74. PubMed ID: 23257665
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative properties of piperidinylchalcones.
Liu X; Go ML
Bioorg Med Chem; 2006 Jan; 14(1):153-63. PubMed ID: 16185876
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
11. Different effects of two cyclic chalcone analogues on cell cycle of Jurkat T cells.
Rozmer Z; Berki T; Perjési P
Toxicol In Vitro; 2006 Dec; 20(8):1354-62. PubMed ID: 16828254
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative activity of chalcones with basic functionalities.
Liu X; Go ML
Bioorg Med Chem; 2007 Nov; 15(22):7021-34. PubMed ID: 17804245
[TBL] [Abstract][Full Text] [Related]
13. Solid-phase synthesis of 2'-hydroxychalcones. Effects on cell growth inhibition, cell cycle and apoptosis of human tumor cell lines.
Neves MP; Cravo S; Lima RT; Vasconcelos MH; Nascimento MS; Silva AM; Pinto M; Cidade H; Corrêa AG
Bioorg Med Chem; 2012 Jan; 20(1):25-33. PubMed ID: 22177409
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure, and in vitro antitumor activity of some glycoside derivatives of ferrocenyl-chalcones and ferrocenyl-pyrazolines.
Zsoldos-Mády V; Csámpai A; Szabó R; Mészáros-Alapi E; Pásztor J; Hudecz F; Sohár P
ChemMedChem; 2006 Oct; 1(10):1119-25. PubMed ID: 16944543
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological screening of a combinatorial library of beta-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents.
Bandgar BP; Gawande SS
Bioorg Med Chem; 2010 Mar; 18(5):2060-5. PubMed ID: 20138527
[TBL] [Abstract][Full Text] [Related]
16. Superior anticancer activity of halogenated chalcones and flavonols over the natural flavonol quercetin.
Dias TA; Duarte CL; Lima CF; Proença MF; Pereira-Wilson C
Eur J Med Chem; 2013 Jul; 65():500-10. PubMed ID: 23771043
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cytotoxic, anti-inflammatory, and anti-oxidant activities of 2',5'-dialkoxylchalcones as cancer chemopreventive agents.
Cheng JH; Hung CF; Yang SC; Wang JP; Won SJ; Lin CN
Bioorg Med Chem; 2008 Aug; 16(15):7270-6. PubMed ID: 18606546
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents.
Bandgar BP; Gawande SS; Bodade RG; Totre JV; Khobragade CN
Bioorg Med Chem; 2010 Feb; 18(3):1364-70. PubMed ID: 20064725
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic activity of 4'-hydroxychalcone derivatives against Jurkat cells and their effects on mammalian DNA topoisomerase I.
Gul HI; Cizmecioglu M; Zencir S; Gul M; Canturk P; Atalay M; Topcu Z
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):804-7. PubMed ID: 18830876
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of prenylated chalcones as 5-LOX inhibitors.
Reddy NP; Aparoy P; Reddy TC; Achari C; Sridhar PR; Reddanna P
Bioorg Med Chem; 2010 Aug; 18(16):5807-15. PubMed ID: 20667741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
